Aclaris Therapeutics Stock (NASDAQ: ACRS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 847.00 / 832.50K |
Day Range | - - - |
52 Wk Range | 0.59 - 11.12 |
Market Cap | $86.94M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 7.46% |
Days to Cover | 7.91 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aclaris Therapeutics (NASDAQ:ACRS) through any online brokerage.
Other companies in Aclaris Therapeutics’s space includes: SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Lipocine (NASDAQ:LPCN), Rani Therapeutics Hldgs (NASDAQ:RANI) and Marinus Pharma (NASDAQ:MRNS).
There is no analysis for Aclaris Therapeutics.
Aclaris Therapeutics has a consensus price target of $6.29.
The stock price for Aclaris Therapeutics (NASDAQ: ACRS) is $1.22 last updated Today at July 3, 2024 at 7:47 AM EDT.
There are no upcoming dividends for Aclaris Therapeutics.
Aclaris Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Aclaris Therapeutics.
Aclaris Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.